192
Views
16
CrossRef citations to date
0
Altmetric
Perspective

Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection?

&
Pages 465-477 | Published online: 10 Jan 2014

References

  • Rapin I, Tuchman RF. Autism: definition, neurobiology, screening, diagnosis. Pediatr. Clin. North Am.55(5), 1129–1146 (2008).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington, DC, USA (1994).
  • American Association of Pediatrics Council. Identification and evaluation of children with autism spectrum disorders. Pediatrics120(5), 1183–1215 (2007).
  • White JF. Intestinal pathophysiology in autism. Exp. Biol. Med.228(6), 639–649 (2003).
  • Autism and Developmental Disabilities Monitoring Network Surveillance year 2002 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders – autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill. Summ.56, 12–28 (2007).
  • Giarelli E, Wiggins LD, Rice CE et al. Sex differences in the evaluation and diagnosis of autism spectrum disorders among children. Disabil. Health J.3(2), 107–116 (2010).
  • El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr. Clin. North Am.33(1), 83–105 (2010).
  • Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics113(5), e472–e486 (2004).
  • Bailey A, Le Couteur A, Gottesman I et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med.25(1), 63–77 (1995).
  • Costa e Silva J. Autism, a brain developmental disorder: some new pathopysiologic and genetics findings. Metabolism57, S40–S43 (2008).
  • Rosenfeld JA, Ballif BC, Torchia BS et al. Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet. Med.12(11), 694–702 (2010).
  • Hughes JR. Autism: the first firm finding = underconnectivity? Epilepsy Behav.11, 20–24 (2007).
  • Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol.17(4), 434–447 (2007).
  • Lawler CP, Croen LA, Grether JK, Van de Water J. Identifying environmental contributions to autism: provocative clues and false leads. Ment. Retard. Dev. Disabil. Res. Rev.10, 292–302 (2004).
  • Goodwin MS, Cowen MA, Goodwin TC. Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children. J. Autism Child. Schizophr.1(1), 48–62 (1971).
  • Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol.14(6), 388–394 (1999).
  • Atladóttir HO, Pedersen MG, Thorsen P et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics124(2), 687–694 (2009).
  • Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun. Rev.3(7–8), 557–562 (2004).
  • Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol.80(1), 1–15 (2006).
  • Careaga M, Van de Water J, Ashwood P. Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics7(3), 283–292 (2010).
  • Castellani ML, Conti CM, Kempuraj DJ et al. Autism and immunity: revisited study. Int. J. Immunopathol. Pharmacol.22(1), 15–19 (2009).
  • Chez MG, Guido-Estrada N. Immune therapy in autism: historical experience and future directions with immunomodulatory therapy. Neurotherapeutics7(3), 293–301 (2010).
  • Hornig M, Lipkin WI. Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models. Ment. Retard. Dev. Disabil. Res. Rev.7(3), 200–210 (2001).
  • Money J, Bobrow NA, Clarke FC. Autism and autoimmune disease: a family study. J. Autism Child. Schizophr.1, 146 (1971).
  • Stubbs EG. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J. Autism Child. Schizophr.6(3), 269–274 (1976).
  • Libbey JE, Coon HH, Kirkman NJ et al. Are there altered antibody responses to measles, mumps, or rubella viruses in autism? J. Neurovirol.13(3), 252–259 (2007).
  • Weizman A, Weizman R, Szekely GA, Wijsenbeek H, Livni E. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am. J. Psychiatry139(11), 1426–1425 (1982).
  • Singh VK, Jensen RL. Elevated levels of measles antibodies in children with autism. Pediatr. Neurol.28(4), 292–294 (2003).
  • Rout UK, Dhossche DM. A pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies. Med. Hypotheses71(2), 218–221 (2008).
  • Jepson B, Johnson J. Changing the Course of Autism. A Scientific Approach for Parents and Physicians. Sentient Publications, Boulder, CO, USA (2007).
  • Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann. NY Acad. Sci.1107, 79–91 (2007).
  • Li X, Chauhan A, Sheikh AM et al. Elevated immune response in the brain of autistic patients. J. Neuroimmunol.207(1–2), 111–116 (2009).
  • Warren RP, Margaretten NC, Pace NC, Foster A. Immune abnormalities in patients with autism. J. Autism Dev. Disord.16(2), 189–197 (1986).
  • Warren RP, Margaretten NC, Foster A. Reduced natural killer cell activity in autism. J. Am. Acad. Child Adolesc. Psychiatry26(3), 333–335 (1987).
  • Trajkovski V, Ajdinski L, Spiroski M. Plasma concentration of immunoglobulin classes and subclasses in children with autism in the Republic of Macedonia: retrospective study. Croat. Med. J.45(6), 746–749 (2004).
  • Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol.57, 67–81 (2005).
  • Vojdani A, Mumper E, Granpeesheh D et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J. Neuroimmunol.205(1–2), 148–154 (2008).
  • Heuer L, Ashwood P, Schauer J et al. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res.1(5), 275–283 (2008).
  • Santaella ML, Varela Y, Linares N, Disdier OM. Prevalence of autism spectrum disorders in relatives of patients with selective immunoglobulin A deficiency. P. R. Health Sci. J.27(3), 204–208 (2008).
  • Kanner L. Autistic disturbances of affective contact. Nervous Child (Edition 2). In: Classic Readings in Autism. Donnellan AM (Ed.). Teacher’s College Press, NY, USA, 217–250 (1985).
  • Konstantareas MM, Homatidis S. Ear infections in autistic and normal children. J. Autism Dev. Disord.17(4), 585–594 (1987).
  • Niehus R, Lord C. Early medical history of children with autism spectrum disorders. J. Dev. Behav. Pediatr.27(2 Suppl.), S120–S127 (2006).
  • Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J. Neuroinflammation5(1), 52 (2008).
  • Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics118(4), e1203–e1211 (2006).
  • Gurney JG, Fritz MS, Ness KK, Sievers P, Newschaffer CJ, Shapiro EG. Analysis of prevalence trends or autism spectrum disorder in Minnesota. Arch. Pediatr. Adolesc. Med.157(7), 622–627 (2003).
  • Kawashti MI, Amin OR, Rowehy NG. Possible immunological disorders in autism: concomitant autoimmunity and immune tolerance. Egypt J. Immunol.13(1), 99–104 (2006) (Abstract).
  • van Gent T, Heijnen CJ, Treffers PD. Autism and the immune system. J. Child Psychol. Psychiatry38(3), 337–349 (1997).
  • Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci.23(1), 297–302 (2003).
  • Shi L, Smith SE, Malkova N, Tse D, Su Y, Patterson PH. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun.23(1), 116–123 (2009).
  • Fatemi SH, Folsom TD, Reutiman TJ et al. Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice. Schizophr. Res.112(1–3), 46–53 (2009).
  • Fatemi SH, Reutiman TJ, Folsom TD et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res.99(1–3), 56–70 (2008).
  • Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry167(3), 261–280 (2010).
  • Atladóttir HO, Thorsen P, Ostergaard L et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord.40(12), 1423–1430 (2010).
  • Meyer U, Nyffeler M, Engler A et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci.26(18), 4752–4762 (2006).
  • Dalton P, Deacon R, Blamire A et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol.53(4), 533–537 (2003).
  • Warren RP, Cole P, Odell JD et al. Detection of maternal antibodies in infantile autism. J. Am. Acad. Child Adolesc. Psychiatry.29(6), 873–877 (1990).
  • Zimmerman AW, Connors SL, Matteson KJ et al. Maternal antibrain antibodies in autism. Brain Behav. Immun.21(3), 351–357 (2007).
  • Braunschweig D, Ashwood P, Krakowiak P, et al. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology29(2), 226–231 (2008).
  • Arvanitakis C. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn’s disease. Digestion19(4), 259–266 (1979).
  • Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics124, 680–686 (2009).
  • Brown AC, Chow D, Murakami S et al. Possible gastrointestinal symptoms in a subset of children with autism. Expert Rev. Gastroenterol. Hepatol.4(2), 125–127 (2010).
  • Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case–control study using data from the UK General Practice Research Database. BMJ325(7361), 419–421 (2002).
  • Kuddo T, Nelson KB. How common are gastrointestinal disorders in children with autism? Curr. Opin. Pediatr.15(3), 339–343 (2003).
  • Pavone L, Fumara A, Bottaro G, Mazzone D, Coleman M. Autism and celiac disease: failture to validate the hypothesis that a link might exist. Biol. Psychiatry42(1), 72–75 (1997).
  • Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr.135(5), 559–563 (1999).
  • Quigley EM, Hurley D. Autism and the gastrointestinal tract. Am. J. Gastroenterol.95(9), 2154–2156 (2000).
  • Ahern WH. An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. J. Autism Dev. Disord.31(5), 505–511 (2001).
  • Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ. Gastrointestinal factors in autistic disorder: a critical review. J. Autism Dev. Disord.35(6), 713–727 (2005).
  • Schreck KA, Williams K. Food preferences and factors influencing food selectivity for children with autism spectrum disorders. Res. Dev. Disabil.27(4), 353–363 (2006).
  • Schreck KA, Williams K, Smith AF. A comparison of eating behaviors between children with and without autism. J. Autism Dev. Disord.34(4), 433–438 (2004).
  • Buie T, Campbell DB, Fuchs GJ III et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics125(Suppl. 1), S1–S18 (2010).
  • D’Eufemia P, Celli M, Finocchiaro R et al. Abnormal intestinal permeability in children with autism. Acta Paediat.85(9), 1076–1079 (1996).
  • Lightdale JR, Hayer C, Duer A et al. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Pediatrics108(5), E90 (2001).
  • Levy SE, Souders MC, Ittenbach RF, Giarelli E, Mulberg AE, Pinto-Martin JA. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol. Psychiatry61(4), 492–497 (2007).
  • Valicenti-McDermott MD, McVicar K, Cohen HJ, Wershil BK, Shinnar S. Gastrointestinal symptoms in children with an autism spectrum disorder and language regression. Pediatr. Neurol.39(6), 392–398 (2008).
  • Wakefield AJ, Murch SH, Anthony A et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet351(9103), 637–641 (1998).
  • Murch SH, Anthony A, Casson DH et al. Retraction of an interpretation. Lancet363(9411), 750 (2004).
  • Wakefield AJ, Anthony A, Murch SH et al. Enterocolitis in children with developmental disorders. Am. J. Gastroenterol.95(9), 2285–2295 (2000).
  • Torrente F, Anthony A, Heuschkel RB, Thomson MA, Ashwood P, Murch SH. Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s and Helicobacter pylori gastritis. Am. J. Gastroenterol.99(4), 598–605 (2004).
  • Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol.24(6), 664–673 (2004).
  • Fasano A. Surprises from celiac disease. Sci. Am.301(2), 54–61 (2009).
  • Turner JR. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol.9(11), 799–809 (2009).
  • Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology110(3), 967–968 (1996).
  • Reichelt KL, Ekrein J, Sctoo H. Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J. Appl. Nutr.42, 1–11 (1990).
  • Lucarelli S, Frediani T, Zingoni AM et al. Food allergy and infantile autism. Panminerva Med.37(3), 137–141 (1995).
  • Brantl V, Teschemacher H, Bläsig J, Henschen A, Lottspeich F. Opioid activities of β-casomorphins. Life Sci.28(17), 1903–1909 (1981).
  • Nyberg F, Lieberman H, Lindström LH, Lyrenäs S, Koch G, Terenius L. Immunoreactive β-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: correlation with plasma levels. J. Clin. Endocrinol. Metab.68(2), 283–289 (1989).
  • Hemmings WA. The entry into the brain of large molecules derived from dietary protein. Proc. R. Soc. Lond. B Biol. Sci.200(1139), 175–192 (1978).
  • Pankseep J. A neruochemical theory of autism. Trends Neurosci.2, 174–177 (1979).
  • Lipkin WI, Hornig M. Microbiology and immunology of autism spectrum disorders. Novartis Found. Symp.251, 129–143 (2003).
  • Bushara KO. Neurologic presentation of celiac disease. Gastroenterology128(4 Suppl. 1), S92–S97 (2005).
  • Pynnonen PA, Isometsä ET, Verkasalo MA, Savilahti E, Aalberg VA. Untreated celiac disease and development of mental disorders in children and adolescents. Psychosomatics43(4), 331–334 (2002).
  • Kalaydjian AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr. Scand.113(2), 82–90 (2006).
  • Sandler RH, Finegold SM, Bolte ER et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol.15(7), 429–435 (2000).
  • Whelan J. Antibiotics: a possible treatment for regressive-onset autism. Drug Discov. Today5(11), 487–488 (2000).
  • Bolte ER. Autism and Clostridium tetani. Med. Hypotheses51(2), 133–144 (1998).
  • Bohmer CJ, Taminiau JA, Klinkenberg-Knol EC, Meuwissen SG. The prevalence of constipation in institutionalized people with intellectual disability. J. Intellect. Disabil. Res.45(Pt 3), 212–218 (2001).
  • Schwartzman F, Vitolo MR, Schwartzman JS, Morais MB. Eating practices, nutritional status and constipation in patients with Rett syndrome. Arq. Gastroenterol.45(4), 284–289 (2008).
  • Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R. Constipation with acquired megarectum in children with autism. Pediatrics112(4), 939–942 (2003).
  • Lotan M, Ben-Zeev B. Rett syndrome. A review with emphasis on clinical characteristics and intervention. Sci. World J.6(6), 1517–1541 (2006).
  • Percy AK, Lane JB. Rett syndrome: model of neurodevelopmental disorders. J. Child Neurol.20(9), 718–721 (2005).
  • Prater CD, Zylstra RG. Medical care of adults with mental retardation. Am. Fam. Physician75(5), 622, 624 (2007).
  • Levy J. The gastrointestinal tract in Down syndrome. Prog. Clin. Biol. Res.373, 245–256 (1991).
  • Hilhorst MI, Brink M, Wauters EA, Houwen RH. Down syndrome and coeliac disease: five new cases with a review of the literature. Eur. J. Pediatr.152(11), 884–887 (1993).
  • Bonamico M, Pasquino AM, Mariani P et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J. Clin. Endocrinol. Metab.87(12), 5495–5498 (2002).
  • Gillett PM, Gillett HR, Israel DM et al. Increased prevalence of celiac disease in girls with Turner syndrome detected using antibodies to endomysium and tissue transglutaminase. Can. J. Gastroenterol.14(11), 915–918 (2000).
  • Gravholt CH. Clinical practice in Turner syndrome. Nat. Clin. Pract. Endocrinol. Metab.1(1), 41–52 (2005).
  • Ivarsson SA, Carlsson A, Bredberg A et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr.88(9), 933–936 (1999).
  • Giannotti A, Tiberio G, Castro M et al. Coeliac disease in Williams syndrome. J. Med. Genet.38(11), 767–768 (2001).
  • Rujner J, Wisniewski A, Gregorek H, Wozniewicz B, Mlynarski W, Witas HW. Coeliac disease and HLA-DQ 2 (DQA1* 0501 and DQB1*0201) in patients with Turner syndrome. J. Pediatr. Gastroenterol. Nutr.32(1), 114–115 (2001).
  • Hill ID, Dirks MH, Liptak GS et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr.40(1), 1–19 (2005).
  • Stenberg R, Dahle C, Lindberg E, Schollin J. Increased prevalence of anti-gliadin antibodies and anti-tissue transglutaminase antibodies in children with cerebral palsy. J. Pediatr. Gastroenterol. Nutr.49(4), 424–429 (2009).
  • Cohen WI. Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability. Am. J. Med. Genet. C Semin. Med. Genet.142C(3), 141–148 (2006).
  • American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care32(Suppl. 1), S13–S61 (2009).
  • Fasano A, Araya M, Bhatnagar S et al. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J. Pediatr. Gastroenterol. Nutr.47(2), 214–219 (2008).
  • Asperger H. Psychopathology of children with celiac disease. Ann. Paediatr.197, 346–351 (1961).
  • Buie T, Fuchs GJ III, Furuta GT et al. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics125(Suppl. 1), S19–S29 (2010).
  • Brown AC, Roy M. Does evidence exist to include dietary therapy in the treatment of Crohn’s disease? Expert Rev. Gastroenterol. Hepatol.4(2), 191–215 (2010).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.